Association of elevated baseline bilirubin caused by preadmission statin use with cardiovascular prognosis in patients undergoing elective percutaneous coronary intervention
Article in Scientific Reports (September 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Prediction models for major adverse cardiovascular events after percutaneous coronary intervention: a systematic review
Article in Frontiers in Cardiovascular Medicine (January 2024)
Bilirubin is a promising target for metabolic and atherosclerotic cardiovascular diseases
Article in Profilakticheskaya meditsina (January 2024)